Followers | 1234 |
Posts | 54656 |
Boards Moderated | 4 |
Alias Born | 11/11/2010 |
Friday, September 17, 2021 10:03:33 AM
Recent ABCL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2024 08:35:34 PM
- AbCellera to Present at Upcoming Investor Conferences in September • Business Wire • 08/29/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:26:59 PM
- AbCellera Reports Q2 2024 Business Results • Business Wire • 08/06/2024 08:05:00 PM
- AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines • Business Wire • 07/31/2024 01:00:00 PM
- AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 • Business Wire • 06/25/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:53:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:21:18 PM
- AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:47:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:22:22 PM
- AbCellera Reports Q1 2024 Business Results • Business Wire • 05/07/2024 08:05:00 PM
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies • Business Wire • 05/01/2024 01:00:00 PM
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 • Business Wire • 04/08/2024 04:05:00 PM
- AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 • Business Wire • 04/03/2024 08:05:00 PM
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 • Business Wire • 03/19/2024 08:05:00 PM
- AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions • Business Wire • 03/11/2024 01:00:00 PM
- AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 • Business Wire • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:49:40 PM
- AbCellera Announces Resignation of Board Member • Business Wire • 02/23/2024 09:30:00 PM
- AbCellera to Present at Upcoming Investor Conferences in March • Business Wire • 02/23/2024 01:15:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2024 09:49:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:27:58 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM